Live Breaking News & Updates on Asset Advisors

Stay updated with breaking news from Asset advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rezolute, Inc. (NASDAQ:RZLT) Sees Large Increase in Short Interest

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 814,600 shares, a growth of 162.0% from the May 15th total of 310,900 shares. Based on an average daily trading volume, of 571,100 shares, […] ....

United-states , Daron-evans , Craig-hallum , Rosalind-advisors-inc , Vanguard-group-inc , Virtu-financial , Acadian-asset-management , Affinity-asset-advisors , Securities-exchange-commission , Rezolute-inc , Nasdaq , Maxim-group

Parkman Healthcare Partners LLC Takes $4.41 Million Position in Nuvalent, Inc. (NASDAQ:NUVL)

Parkman Healthcare Partners LLC acquired a new position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 59,867 shares of the company’s stock, valued at approximately $4,406,000. Parkman Healthcare Partners LLC owned about 0.10% of […] ....

Deborah-ann-miller , Robertw-baird , Nuvalent-inc , Jefferies-financial-group , Affinity-asset-advisors , Charles-schwab-investment-management-inc , Parkman-healthcare-partners , Securities-exchange-commission , First-turn-management , Nasdaq , Free-report , Healthcare-partners

Parkman Healthcare Partners LLC Purchases 51,726 Shares of NewAmsterdam Pharma (NASDAQ:NAMS)

Parkman Healthcare Partners LLC increased its position in shares of NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) by 20.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 300,750 shares of the company’s stock after buying an additional 51,726 shares during the quarter. Parkman Healthcare […] ....

Canada , Jamesn-topper , Newamsterdam-pharma , Schonfeld-strategic-advisors , Royal-bank , Scotiabank , Newamsterdam-pharma-company-profile , Wolverine-asset-management , Parkman-healthcare-partners , Affinity-asset-advisors , Securities-exchange-commission , Newamsterdam-pharma-company

Price T Rowe Associates Inc. MD Sells 976,796 Shares of Baidu, Inc. (NASDAQ:BIDU)

Price T Rowe Associates Inc. MD reduced its stake in Baidu, Inc. (NASDAQ:BIDU – Free Report) by 51.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 932,565 shares of the information services provider’s stock after selling 976,796 shares during the period. […] ....

China , Pricet-rowe-associates-inc , Hermes-inc , Baidu-inc , Invesco-ltd , Baidu-health , Exchange-commission , Baidu-company-profile , Barclays , Asset-advisors , Creek-investment-management-inc

Kura Oncology (NASDAQ:KURA) Trading Down 4.7%

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) dropped 4.7% during trading on Monday . The stock traded as low as $20.43 and last traded at $20.73. Approximately 262,616 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 1,133,167 shares. The stock had previously closed at $21.76. Analyst […] ....

Teresa-brophy-bair , Pricet-rowe-associates-inc , Nasdaq , Avoro-capital-advisors , Artal-group , Affinity-asset-advisors , Platinum-investment-management-ltd , Kura-oncology-inc , Kura-oncology , Get-free-report , Capital-advisors , Asset-advisors